NCT06714019View on ClinicalTrials.gov

PL_GNT01_ISR_Grant 53234273

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 11, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions
Transthyretin Cardiomyopathy (TTR-CM)Transthyretin (TTR) Amyloid CardiomyopathyTransthyretin Amyloidosis
Trial Locations (1)

04-628

National Institute of Cardiology, Warsaw

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

National Institute of Cardiology, Warsaw, Poland

OTHER